Bone Marrow Transplant Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL BONE MARROW TRANSPLANT INDUSTRY

2.1 Summary about Bone Marrow Transplant Industry

2.2 Bone Marrow Transplant Market Trends

2.2.1 Bone Marrow Transplant Production & Consumption Trends

2.2.2 Bone Marrow Transplant Demand Structure Trends

2.3 Bone Marrow Transplant Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Autologous Hematopoietic Stem Cell Transplantation

4.2.2 Syngeneic Hematopoietic Stem Cell Transplantation

4.2.3 Allo-HSCT

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Acute Leukemia

4.3.2 Chronic Leukemia

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Autologous Hematopoietic Stem Cell Transplantation

5.2.2 Syngeneic Hematopoietic Stem Cell Transplantation

5.2.3 Allo-HSCT

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Acute Leukemia

5.3.2 Chronic Leukemia

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Autologous Hematopoietic Stem Cell Transplantation

6.2.2 Syngeneic Hematopoietic Stem Cell Transplantation

6.2.3 Allo-HSCT

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Acute Leukemia

6.3.2 Chronic Leukemia

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Autologous Hematopoietic Stem Cell Transplantation

7.2.2 Syngeneic Hematopoietic Stem Cell Transplantation

7.2.3 Allo-HSCT

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Acute Leukemia

7.3.2 Chronic Leukemia

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Autologous Hematopoietic Stem Cell Transplantation

8.2.2 Syngeneic Hematopoietic Stem Cell Transplantation

8.2.3 Allo-HSCT

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Acute Leukemia

8.3.2 Chronic Leukemia

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Autologous Hematopoietic Stem Cell Transplantation

9.2.2 Syngeneic Hematopoietic Stem Cell Transplantation

9.2.3 Allo-HSCT

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Acute Leukemia

9.3.2 Chronic Leukemia

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 AllCells (USA)

10.1.2 Lonza (Switzerland)

10.1.3 Merck (USA)

10.1.4 Sanofi (France)

10.1.5 Translational Biosciences (USA)

10.1.6 Athersys (USA)

10.1.7 Beike Biotechnology (China)

10.1.8 BioTime (USA)

10.1.9 Bluebird Bio (USA)

10.1.10 Caladrius (USA)

10.1.11 Cellular Biomedicine Group (USA)

10.1.12 Cesca Therapeutics (USA)

10.1.13 TiGenix (Belgium)

10.1.14 CHA Biotech (Korea)

10.1.15 Chugai Pharmaceutical (UK)

10.1.16 CORESTEM (Korea)

10.1.17 Gamida Cell (USA)

10.1.18 Histocell (Spain)

10.1.19 Hemostemix (Canada)

10.2 Bone Marrow Transplant Sales Date of Major Players (2017-2020e)

10.2.1 AllCells (USA)

10.2.2 Lonza (Switzerland)

10.2.3 Merck (USA)

10.2.4 Sanofi (France)

10.2.5 Translational Biosciences (USA)

10.2.6 Athersys (USA)

10.2.7 Beike Biotechnology (China)

10.2.8 BioTime (USA)

10.2.9 Bluebird Bio (USA)

10.2.10 Caladrius (USA)

10.2.11 Cellular Biomedicine Group (USA)

10.2.12 Cesca Therapeutics (USA)

10.2.13 TiGenix (Belgium)

10.2.14 CHA Biotech (Korea)

10.2.15 Chugai Pharmaceutical (UK)

10.2.16 CORESTEM (Korea)

10.2.17 Gamida Cell (USA)

10.2.18 Histocell (Spain)

10.2.19 Hemostemix (Canada)

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Bone Marrow Transplant Product Type Overview

2.Table Bone Marrow Transplant Product Type Market Share List

3.Table Bone Marrow Transplant Product Type of Major Players

4.Table Brief Introduction of AllCells (USA)

5.Table Brief Introduction of Lonza (Switzerland)

6.Table Brief Introduction of Merck (USA)

7.Table Brief Introduction of Sanofi (France)

8.Table Brief Introduction of Translational Biosciences (USA)

9.Table Brief Introduction of Athersys (USA)

10.Table Brief Introduction of Beike Biotechnology (China)

11.Table Brief Introduction of BioTime (USA)

12.Table Brief Introduction of Bluebird Bio (USA)

13.Table Brief Introduction of Caladrius (USA)

14.Table Brief Introduction of Cellular Biomedicine Group (USA)

15.Table Brief Introduction of Cesca Therapeutics (USA)

16.Table Brief Introduction of TiGenix (Belgium)

17.Table Brief Introduction of CHA Biotech (Korea)

18.Table Brief Introduction of Chugai Pharmaceutical (UK)

19.Table Brief Introduction of CORESTEM (Korea)

20.Table Brief Introduction of Gamida Cell (USA)

21.Table Brief Introduction of Histocell (Spain)

22.Table Brief Introduction of Hemostemix (Canada)

23.Table Products & Services of AllCells (USA)

24.Table Products & Services of Lonza (Switzerland)

25.Table Products & Services of Merck (USA)

26.Table Products & Services of Sanofi (France)

27.Table Products & Services of Translational Biosciences (USA)

28.Table Products & Services of Athersys (USA)

29.Table Products & Services of Beike Biotechnology (China)

30.Table Products & Services of BioTime (USA)

31.Table Products & Services of Bluebird Bio (USA)

32.Table Products & Services of Caladrius (USA)

33.Table Products & Services of Cellular Biomedicine Group (USA)

34.Table Products & Services of Cesca Therapeutics (USA)

35.Table Products & Services of TiGenix (Belgium)

36.Table Products & Services of CHA Biotech (Korea)

37.Table Products & Services of Chugai Pharmaceutical (UK)

38.Table Products & Services of CORESTEM (Korea)

39.Table Products & Services of Gamida Cell (USA)

40.Table Products & Services of Histocell (Spain)

41.Table Products & Services of Hemostemix (Canada)

42.Table Market Distribution of Major Players

43.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

44.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

45.Table Global Bone Marrow Transplant Market Forecast (Million USD) by Region 2021f-2026f

46.Table Global Bone Marrow Transplant Market Forecast (Million USD) Share by Region 2021f-2026f

47.Table Global Bone Marrow Transplant Market Forecast (Million USD) by Demand 2021f-2026f

48.Table Global Bone Marrow Transplant Market Forecast (Million USD) Share by Demand 2021f-2026f